NASDAQ:ELTX | Cash Flow Statement | Elicio Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$8.22M
2026-03-31-$11.82M-$11.65M$8.03M
2025-12-31-$7.72M-$6.8M$16,000.00-$16,000.00$4.86M
2025-09-30-$10.08M
2025-06-30-$10.56M
2025-03-31-$11.21M-$10.12M$0.00$10.33M
2024-12-31-$14M-$8.74M$45,000.00-$45,000.00$227,000.00
2024-09-30-$18.84M
2024-06-30-$7.23M
2024-03-31-$11.83M-$12.12M$0.00$3,000.00$11.02M
2023-12-31-$8.95M-$9.9M$0.00$0.00$7M
2023-09-30-$10.66M
2023-06-30-$7.56M
2023-03-31-$8.03M-$8.14M$17,000.00-$17,000.00$10.04M
2022-12-31-$6.65M-$7.28M$95,000.00-$95,000.00$11.18M
2022-09-30-$7.2M
2022-06-30-$7.3M
2022-03-31-$7.06M-$15.65M$0.00$0.00-$14,000.00
2021-12-31$14.89M-$14.36M$36,000.00-$36,000.00$404,000.00
2021-09-30-$15.7M
2021-06-30-$17.07M
2021-03-31-$36.69M-$12.55M$41,000.00-$41,000.00$108.44M
2020-12-31-$28.88M$20.59M$10,000.00-$10,000.00$202,000.00
2020-09-30-$17.67M
2020-06-30-$20.34M
2020-03-31-$13.22M-$8.73M$20,000.00-$20,000.00$3.94M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$39.57M-$36.95M$16,000.00-$16,000.00$36.7M
2024-12-31-$51.9M-$37.07M$87,000.00-$84,000.00$42.32M
2023-12-31-$35.2M-$32.69M$66,000.00-$32,000.00$38.61M
2022-12-31-$28.21M-$22.18M$654,000.00-$654,000.00$21.2M
2021-12-31-$54.57M-$52.64M$382,000.00-$382,000.00$107.17M
2020-12-31-$80.11M-$22.89M$41,000.00-$41,000.00$52.41M